Vimarsana
Biggest News Aggregation in the World

Page 10 - Invo Bioscience News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Invo Bioscience. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Invo Bioscience Today - Breaking & Trending Today

INVO Bioscience (NASDAQ:INVO) Upgraded to "Buy" by Zacks Investment Research - Vimarsana News

INVO Bioscience (NASDAQ:INVO) Upgraded to "Buy" by Zacks Investment Research

Zacks Investment Research upgraded shares of INVO Bioscience (NASDAQ:INVO – Get Rating) from a hold rating to a buy rating in a report issued on Friday morning, Zacks.com reports. They currently have $2.25 price objective on the stock. According to Zacks, “INVO Bioscience is a medical device company, headquartered in Beverly, Massachusetts, focused on creating […]

INVO Selects Kansas City as additional INVO Center Location - Vimarsana News

INVO Selects Kansas City as additional INVO Center Location

/PRNewswire/ -- INVO Bioscience, Inc. (NASDAQ: INVO) ("INVO" or the "Company"), a commercial-stage fertility company focused on expanding access to advanced...

INVO Bioscience Reports 2021 Financial Results - Vimarsana News

INVO Bioscience Reports 2021 Financial Results

/PRNewswire/ -- INVO Bioscience, Inc. (Nasdaq: INVO) ("INVO" or the "Company"), a commercial-stage fertility company focused on expanding access to advanced...

INVO Bioscience (INVO) Set to Announce Quarterly Earnings on Thursday - Vimarsana News

INVO Bioscience (INVO) Set to Announce Quarterly Earnings on Thursday

INVO Bioscience (NASDAQ:INVO – Get Rating) will be announcing its earnings results after the market closes on Thursday, March 31st. Analysts expect the company to announce earnings of ($0.24) per share for the quarter. Investors interested in registering for the company’s conference call can do so using this link. INVO opened at $2.75 on Tuesday. […]

Reviewing Haemonetics (NYSE:HAE) and INVO Bioscience (NASDAQ:INVO) - Vimarsana News

Reviewing Haemonetics (NYSE:HAE) and INVO Bioscience (NASDAQ:INVO)

INVO Bioscience (NASDAQ:INVO – Get Rating) and Haemonetics (NYSE:HAE – Get Rating) are both medical companies, but which is the better investment? We will compare the two companies based on the strength of their analyst recommendations, risk, profitability, dividends, valuation, institutional ownership and earnings. Institutional & Insider Ownership 14.8% of INVO Bioscience shares are held […]